17β-Estradiol inhibits forskolin-induced vascular endothelial growth factor promoter in MCF-7 breast adenocarcinoma cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 78, Issue 4, 2001, Pages 343-349

  Bermont, Laurent ^a   Lamielle Musard, Frédérique ^a   Chezy, Evelyne ^a   Weisz, Alessandro ^b   Adessi, Gérard L ^a  

^a Service d'Oncologie et d'Endocrinologie Moléculaires   (France)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

CAMP pathway; Estrogens; MCF 7 breast cancer cells; Transient transfection; VEGF promoter

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; LIGAND; VASCULOTROPIN; CYCLIC AMP; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; PRIMER DNA; VASCULOTROPIN A;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DRUG ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ADENOCARCINOMA; BREAST TUMOR; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADENOCARCINOMA; BASE SEQUENCE; BREAST NEOPLASMS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; FORSKOLIN; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; LYMPHOKINES; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034746998     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00111-X     Document Type: Article

References (39)

1. Angiogenesis
2. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
3. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways
4. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells
5. Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells
6. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells
7. Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: Potential relevance to menstruation and endometrial regeneration
8. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a β-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2
9. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells
10. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
11. Vascular permeability factor/vascular endothelial growth factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
12. Vascular endothelial growth factor expression is not regulated by estradiol or medroxyprogesterone acetate in endometrial carcinoma
13. Regulation of vascular endothelial growth factor expression by estrogens and progestins
14. Vascular endothelial growth factor A (VEGF-A) mRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions
15. Cholera-toxin-enhanced growth of human breast cancer cell lines in vitro and in vivo: Interaction with estrogen
16. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol
17. Interaction between estradiol and cAMP in the regulation of specific gene expression
18. 17β-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures
19. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element
20. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells
21. Enhanced responses to 17β-estradiol in rat hearts treated with isoproterenol: Involvement of a cyclic AMP-dependent pathway
22. Regulation of vascular endothelial growth factor expression by insulin-like growth factor in endometrial adenocarcinoma cells
23. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells
24. Hypoxia regulatory elements of the human vascular endothelial growth factor gene
25. Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription
26. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
27. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathway
28. Two Sp1-binding sites mediate cAMP-induced transcription of the bovine CYP11A gene through the protein kinase A signaling pathway
29. Modulation of transcription factor Sp1 by cAMP-dependent Protein Kinase
30. SP1/SP3-binding sites and adjacent elements contribute to basal and cyclic adenosine 3′,5′-monophosphate-stimulated transcriptional activation of the rhesus growth hormone-variant gene in trophoblasts
31. Role of Sp1 in cAMP-dependent transcriptional regulation of the bovine CYP11A gene
32. Multiple elements and protein factors coordinate the basal and cyclic adenosine 3′,5′-monophosphate-induced transcription of the lutropin receptor gene in rat granulosa cells
33. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptor a and b
34. Identification of functional estrogen response element in the gene coding for the potent angiogenic factor vascular endothelial growth factor
35. Inhibition of vascular endothelial growth factor expression in HEC-1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins
36. Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines
37. Vascular endothelial growth factor is a high prognostic value in node-negative breast carcinoma
38. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy
39. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway